Beruflich Dokumente
Kultur Dokumente
Kidney Functions
Clasification
Renal failure can be divided into two categories:
acute kidney injury
chronic kidney disease.
The type of renal failure is determined by the trend in the
serum creatinine.
Other factors which may help differentiate acute kidney injury
from chronic kidney disease include anemia and the kidney
size on ultrasound. Chronic kidney disease generally leads to
anemia and small kidney size.
Symptoms
Symptoms can vary from person to person.
Someone in early stage kidney disease may not feel sick or
notice symptoms as they occur.
When kidneys fail to filter properly, waste accumulates in the
blood and the body, a condition called azotemia.
If the disease progresses, symptoms become noticeable (if the
failure is of sufficient degree to cause symptoms).
Renal failure accompanied by noticeable symptoms is termed
uraemia
Common presentation of
CKD
Asymptomatic urine abnormalities :
proteinuria/ haematuria
Nephritic/Nephrotic syndrome
Hypertension
Unexplained anaemia
Incidental finding of elevated serum
Creatinine
Uraemic emergencies
Screening Methods
Serum Creatinine
Estimated glomerular filtration rate
(GFR)
Urine testing :
Serum Creatinine
Sr creatinine is poor reflection of early renal
disease/failure
Damage < 60% sr creatinine still normal
Almost all early renal failure patients are
asymptomatic
SCREENING IS THEREFORE VERY IMPORTANT
Man
1.23 x (140-Age) x BW
Sr Cr (umol/l)
Woman
1.04 x (140-Age) x BW
Sr Cr (umol/l)
Continued.
The formula is named after the Modification of
Diet in Renal Disease study in the USA.
The results are expressed relative to a
standard body surface area of 1.73 m 2 to
allow for different body sizes.
The equation is only valid in persons over 17
years of age.
Results >60 mL/min/1.73m 2 are likely to
deviate from the true value and should not be
relied upon.
The use of the eGFR in patients on dialysis is
inappropriate and will give misleading results.
Urine Testing
Urine for protein
Dipstick
24 hour urinary protein
Renal calculi
Anemia of unknown
aetiology
First and second
degree relatives of
ESRD
Autoimmune disease
(SLE/RA)
Reduction of kidney
mass(Nephrectomy
Hypertension
Hyperglycemia
Proteinuria
Coffee
Smoking
Salt
Stages
All individuals with a Glomerular filtration rate (GFR) <60
mL/min/1.73 m2 for 3 months are classified as having chronic
kidney disease, irrespective of the presence or absence of
kidney damage.
The rationale for including these individuals is that reduction
in kidney function to this level or lower represents loss of half
or more of the adult level of normal kidney function, which
may be associated with a number of complications.
Stage 1
Slightly diminished function. Kidney damage with normal or
relatively high GFR (90 mL/min/1.73 m2). Kidney damage is
defined as pathologic abnormalities or markers of damage, including
abnormalities in blood or urine test or imaging studies.
Stage 2
Mild reduction in GFR (60-89 mL/min/1.73 m2) with kidney
damage. Kidney damage is defined as pathologic abnormalities or
markers of damage, including abnormalities in blood or urine test or
imaging studies.
Stage 3
Moderate reduction in GFR (30-59 mL/min/1.73 m2).
Stage 4
Severe reduction in GFR (15-29 mL/min/1.73 m2)
Preparation for renal replacement therapy
Stage 5
Established kidney failure (GFR <15 mL/min/1.73 m2) or
permanent renal replacement therapy (RRT)
KIDNEY FAILURE
ACUTE KIDNEY INJURY
RECURRENT
NORMAL
CKD Stage 2
CKD Stage 3
CKD Stage 4
HEMODYALISIS
PERITONEAL DYALISIS
CKD Stage 5
DYALISIS
TRANSPLANTATION
Treatment
The goal of therapy is to slow down or halt the otherwise
relentless progression of CKD to stage 5.
Control of blood pressure and treatment of the original
disease, whenever feasible, are the broad principles of
management. Generally, ACEIs or ARBs are used, as they
have been found to slow the progression of CKD to stage 5.
Prognosis
The prognosis of patients with chronic kidney disease is guarded as
epidemiological data has shown that all cause mortality (the overall
death rate) increases as kidney function decreases.
The leading cause of death in patients with chronic kidney disease is
cardiovascular disease
While renal replacement therapies can maintain patients indefinitely
and prolong life, the quality of life is severely affected.
Prognosis
Renal transplantation increases the survival of patients with
stage 5 CKD significantly when compared to other therapeutic
options
High intensity home hemodialysis appears to be associated
with improved survival and a greater quality of life, when
compared to the conventional three times a week hemodialysis
and peritoneal dialysis.
Glomerulonephritis
Renal disease characterized by inflammation of the
glomeruli, or small blood vessels in the kidneys.
It may present with isolated hematuria and/or proteinuria
(blood resp. protein in the urine); or as a nephrotic
syndrome, a nephritic syndrome, acute renal failure, or
chronic renal failure.
They are categorised into several different pathological
patterns, which are broadly grouped into nonproliferative or proliferative types.
Diagnosing the pattern of GN is important because the
outcome and treatment differs in different types.
Primary causes are ones which are intrinsic to the
kidney, whilst secondary causes are associated with
certain infections (bacterial, viral or parasitic pathogens),
drugs, systemic disorders (SLE, vasculitis) or diabetes.
Non Proliferative
This is characterised by the numbers of cells (lack of hypercellularity) in the glomeruli.
They usually cause nephrotic syndrome. This includes the following types:
1.
2.
3.
Minimal change GN
Focal Segmental Glomerulosclerosis (FSGS)
Membranous glomerulonephritis
Proliferative
This type is characterised by increased number of cells in the glomerulus (hypercellular).
Usually present as a nephritic syndrome and usually progress to end-stage renal failure
(ESRF) over weeks to years (depending on type).
1.
2.
3.
4.
Minimal change GN
This form of GN causes 80% of nephrotic syndrome
in children, but only 20% in adults.
no changes visible on simple light microscopy, but
on electron microscopy there is fusion of podocytes
(supportive cells in the glomerulus).
Immunohistochemistry staining is negative.
Treatment consists of steroids to halt the disease
process (typically Prednisone 1mg/kg).
Over 90% of children respond well to steroids, being
essentially cured after 3 months of treatment.
Adults have a lower response rate (80%). Failure to
respond to steroids ('steroid resistant') or return of
the disease when steroids are stopped ('steroid
dependent') may require cytotoxic therapy (such as
ciclosporin) which is associated with many sideeffects.